Open access
Oct 2026
Longitudinal kidney outcomes and safety after finerenone initiation in patients with non-diabetic chronic kidney disease: a single-center retrospective cohort study
Finerenone, a non-steroidal mineralocorticoid receptor antagonist, has demonstrated renoprotective effects in randomized controlled trials. However, real-world evidence, particularly in heterogeneous and non-diabetic chronic kidney disease (CKD) populations, remains limited. This was a single-center, retrosp...
Xue-Juan Sun, Juan Pei, Xing Chen et al.
· Frontiers in Medicine · 0 citations